Renalytix (

RENX · AIM · Health Care · mcap £39m · 5.3p

Beta Briefing, track record and bull & bear case are not ready for Renalytix ( yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 38 companies are already wired into a briefing: browse them.

Heights Capital Management, Inc. 10 Oct – 5 Oct · 5 notices

3.9% → 12.8%

share price at the notices 3.1–9.2p · now 5.3p 10 Oct 2025 17 Oct 2025 13 Mar 2026 9 Sep 2026 5 Oct 2026

Unicorn Asset Management Limited 16 Oct – 30 Sep · 4 notices

6.4% → 5.7%

share price at the notices 5.4–8.7p · now 5.3p 16 Oct 2025 8 Sep 2026 16 Sep 2026 30 Sep 2026

Aberdeen Group plc 9 Sep · 1 notice

9.8% → 5.0%

share price at the notices 5.4p · now 5.3p 9 Sep 2026

Pentwater Capital Management LP 8 Sep – 1 Oct · 2 notices

1.4% → 5.0%

share price at the notices 5.4–6.0p · now 5.3p 8 Sep 2026 1 Oct 2026

Renalytix PLC announced that Harwood Capital LLP crossed a threshold due to an increase in the company's total issued share capital 16 Oct · 1 notice

4.4% → 3.9%

share price at the notices 8.7p · now 5.3p 16 Oct 2025

Harwood Capital LLP 16 Sep · 1 notice

2.8% → 3.9%

share price at the notices 6.2p · now 5.3p 16 Sep 2026

First Equity Limited 27 Feb – 14 Sep · 7 notices

below 3% → 2.7%

share price at the notices 1.9–6.4p · now 5.3p 27 Feb 2026 17 Mar 2026 7 Apr 2026 23 Apr 2026 7 Jul 2026 10 Aug 2026 14 Sep 2026

UBS Group AG - Investment Bank & Global Wealth Management 7 Oct – 2 Oct · 48 notices

5.8% → 0.0%

Directors

purchase Renalytix plc announced that Joel Jung, interim Chief Financial Officer, purchased 2,000 American Depositary Shares (ADS) at $2.90 per ADS on February 11, 2026, for a total transaction value of $5,800. Following this pur 12 Feb 2026

purchase Renalytix plc announced that Joel Jung, interim Chief Financial Officer, purchased 500 American Depositary Shares (ADS) at $2.85 per ADS on February 11, 2026. This transaction increases his total interest to 333,855 Ordi 13 Feb 2026

award Renalytix plc announced that Non-Executive Chair Julian Baines MBE intends to step down on December 31, 2026, following the company's recent £10.5 million gross proceeds fundraising and a multi-year partnership with Ques 28 Sep 2026

purchase Renalytix plc announced that on September 29, 2026, investment vehicles connected to Non-Executive Director Christopher Mills purchased 1,166,667 ordinary shares at £0.06 per share, totaling £70,000. Following this trans 1 Oct 2026

purchase Renalytix plc announced that on September 29, 2026, investment vehicles connected with Non-Executive Director Christopher Mills purchased 1,166,667 ordinary shares at £0.06 per share, totaling £70,000. Following this tra 2 Oct 2026

Company filings. Not investment advice.